Vemurafenib Terminated Phase 1 Trials for Melanoma / Metastatic Cancers Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01400451Ph I Ipilimumab Vemurafenib Combo in Patients With v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)
NCT01585415Vemurafenib and White Blood Cell Therapy for Advanced Melanoma
NCT01611675Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma